{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:22:19Z","timestamp":1790792539290,"version":"4.1.0"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Key Project of Sichuan Provincial Department of Science and Technology","award":["2019YFS0532"],"award-info":[{"award-number":["2019YFS0532"]}]},{"DOI":"10.13039\/501100019014","name":"Chengdu Municipal Science and Technology Program","doi-asserted-by":"publisher","award":["2021-YF05-01725-SN"],"award-info":[{"award-number":["2021-YF05-01725-SN"]}],"id":[{"id":"10.13039\/501100019014","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00109-025-02553-w","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T08:48:25Z","timestamp":1748076505000},"page":"739-754","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The role of innate immunity triggered by HPV infection in promoting cervical lesions"],"prefix":"10.1007","volume":"103","author":[{"given":"Kaiyu","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengpei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9221-6727","authenticated-orcid":false,"given":"Rutie","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,24]]},"reference":[{"issue":"5","key":"2553_CR1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1056\/NEJMra2206346","volume":"388","author":"A Mantovani","year":"2023","unstructured":"Mantovani A, Garlanda C (2023) Humoral innate immunity and acute-phase proteins. N Engl J Med 388(5):439\u2013452","journal-title":"N Engl J Med"},{"key":"2553_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1146\/annurev-immunol-061020-053707","volume":"39","author":"M Cabeza-Cabrerizo","year":"2021","unstructured":"Cabeza-Cabrerizo M et al (2021) Dendritic cells revisited. Annu Rev Immunol 39:131\u2013166","journal-title":"Annu Rev Immunol"},{"issue":"7730","key":"2553_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41586-018-0657-2","volume":"563","author":"T Hagai","year":"2018","unstructured":"Hagai T et al (2018) Gene expression variability across cells and species shapes innate immunity. Nature 563(7730):197\u2013202","journal-title":"Nature"},{"issue":"1","key":"2553_CR4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","volume":"6","author":"D Li","year":"2021","unstructured":"Li D, Wu M (2021) Pattern recognition receptors in health and diseases. Signal Transduct Target Ther 6(1):291","journal-title":"Signal Transduct Target Ther"},{"key":"2553_CR5","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3389\/fimmu.2020.01081","volume":"11","author":"T St\u00f6gerer","year":"2020","unstructured":"St\u00f6gerer T, St\u00e4ger S (2020) Innate immune sensing by cells of the adaptive immune system. Front Immunol 11:1081","journal-title":"Front Immunol"},{"issue":"11","key":"2553_CR6","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1038\/s12276-023-01118-6","volume":"55","author":"L-Z Kong","year":"2023","unstructured":"Kong L-Z et al (2023) Understanding nucleic acid sensing and its therapeutic applications. Exp Mol Med 55(11):2320\u20132331","journal-title":"Exp Mol Med"},{"issue":"5","key":"2553_CR7","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s12276-021-00602-1","volume":"53","author":"Y Kasuga","year":"2021","unstructured":"Kasuga Y et al (2021) Innate immune sensing of coronavirus and viral evasion strategies. Exp Mol Med 53(5):723\u2013736","journal-title":"Exp Mol Med"},{"issue":"4","key":"2553_CR8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/ni.3123","volume":"16","author":"A Iwasaki","year":"2015","unstructured":"Iwasaki A, Medzhitov R (2015) Control of adaptive immunity by the innate immune system. Nat Immunol 16(4):343\u2013353","journal-title":"Nat Immunol"},{"key":"2553_CR9","doi-asserted-by":"crossref","unstructured":"Burd EM (2003) Human papillomavirus and cervical cancer. Clin Microbiol Rev 16(1):1\u201317","DOI":"10.1128\/CMR.16.1.1-17.2003"},{"key":"2553_CR10","doi-asserted-by":"crossref","unstructured":"James CD et al (2020) Activating the DNA damage response and suppressing innate immunity: human papillomaviruses walk the line. Pathogens (Basel, Switzerland) 9(6):467","DOI":"10.3390\/pathogens9060467"},{"key":"2553_CR11","doi-asserted-by":"crossref","unstructured":"Lo Cigno I et al (2020) Subversion of host innate immunity by human papillomavirus oncoproteins. Pathogens (Basel, Switzerland) 9(4):292","DOI":"10.3390\/pathogens9040292"},{"issue":"8","key":"2553_CR12","doi-asserted-by":"publisher","first-page":"782","DOI":"10.2174\/1389450123666211221160632","volume":"23","author":"R Vanajothi","year":"2022","unstructured":"Vanajothi R et al (2022) HPV-mediated cervical cancer: a systematic review on immunological basis, molecular biology, and immune evasion mechanisms. Curr Drug Targets 23(8):782\u2013801","journal-title":"Curr Drug Targets"},{"issue":"21","key":"2553_CR13","doi-asserted-by":"publisher","first-page":"11451","DOI":"10.1128\/JVI.78.21.11451-11460.2004","volume":"78","author":"K M\u00fcnger","year":"2004","unstructured":"M\u00fcnger K et al (2004) Mechanisms of human papillomavirus-induced oncogenesis. J Virol 78(21):11451\u201311460","journal-title":"J Virol"},{"issue":"1\u20132","key":"2553_CR14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.virol.2013.04.017","volume":"445","author":"JW Wang","year":"2013","unstructured":"Wang JW, Roden RB (2013) L2, the minor capsid protein of papillomavirus. Virology 445(1\u20132):175\u2013186","journal-title":"Virology"},{"issue":"II","key":"2553_CR15","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1016\/S0959-8049(00)00121-0","volume":"36","author":"K Kurvinen","year":"2000","unstructured":"Kurvinen K et al (2000) Variants of the long control region of human papillomavirus. European Journal of Cancer 36(II):1402\u20131410","journal-title":"European Journal of Cancer"},{"key":"2553_CR16","doi-asserted-by":"crossref","unstructured":"Moody CA (2022) Regulation of the innate immune response during the human papillomavirus life cycle. Viruses 14(8):1797","DOI":"10.3390\/v14081797"},{"key":"2553_CR17","doi-asserted-by":"publisher","first-page":"918190","DOI":"10.3389\/fimmu.2022.918190","volume":"13","author":"W Dai","year":"2022","unstructured":"Dai W et al (2022) The association of cervicovaginal Langerhans cells with clearance of human papillomavirus. Front Immunol 13:918190","journal-title":"Front Immunol"},{"key":"2553_CR18","doi-asserted-by":"publisher","first-page":"110266","DOI":"10.1016\/j.virol.2024.110266","volume":"600","author":"T Kono","year":"2024","unstructured":"Kono T, Ozawa H, Laimins L (2024) The roles of DNA damage repair and innate immune surveillance pathways in HPV pathogenesis. Virology 600:110266","journal-title":"Virology"},{"issue":"1","key":"2553_CR19","doi-asserted-by":"publisher","first-page":"11642","DOI":"10.1038\/s41598-018-30051-2","volume":"8","author":"JR Taylor","year":"2018","unstructured":"Taylor JR et al (2018) Heterotetrameric annexin A2\/S100A10 (A2t) is essential for oncogenic human papillomavirus trafficking and capsid disassembly, and protects virions from lysosomal degradation. Sci Rep 8(1):11642","journal-title":"Sci Rep"},{"key":"2553_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.smim.2017.08.014","volume":"34","author":"MO Mohsen","year":"2017","unstructured":"Mohsen MO et al (2017) Major findings and recent advances in virus-like particle (VLP)-based vaccines. Semin Immunol 34:123\u2013132","journal-title":"Semin Immunol"},{"issue":"6","key":"2553_CR21","doi-asserted-by":"publisher","first-page":"e29685","DOI":"10.1002\/jmv.29685","volume":"96","author":"I Lo Cigno","year":"2024","unstructured":"Lo Cigno I et al (2024) High-risk HPV oncoproteins E6 and E7 and their interplay with the innate immune response: Uncovering mechanisms of immune evasion and therapeutic prospects. J Med Virol 96(6):e29685","journal-title":"J Med Virol"},{"key":"2553_CR22","doi-asserted-by":"crossref","unstructured":"Murayama T et al (2024) Targeting DHX9 triggers tumor-intrinsic interferon response and replication stress in Small Cell Lung Cancer. Cancer Discov 14(3):468-91","DOI":"10.1158\/2159-8290.CD-23-0486"},{"key":"2553_CR23","doi-asserted-by":"crossref","unstructured":"Ni H et al (2022) T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer. J Immunother Cancer 10(9):e005151","DOI":"10.1136\/jitc-2022-005151"},{"issue":"suppl 1","key":"2553_CR24","doi-asserted-by":"publisher","first-page":"e549s","DOI":"10.6061\/clinics\/2018\/e549s","volume":"73","author":"RAL Nunes","year":"2018","unstructured":"Nunes RAL et al (2018) Innate immunity and HPV: friends or foes. Clinics (Sao Paulo, Brazil) 73(suppl 1):e549s","journal-title":"Clinics (Sao Paulo, Brazil)"},{"key":"2553_CR25","doi-asserted-by":"publisher","first-page":"1407649","DOI":"10.3389\/fimmu.2024.1407649","volume":"15","author":"S-Y Qi","year":"2024","unstructured":"Qi S-Y et al (2024) The HPV viral regulatory mechanism of TLRs and the related treatments for HPV-associated cancers. Front Immunol 15:1407649","journal-title":"Front Immunol"},{"issue":"1","key":"2553_CR26","doi-asserted-by":"publisher","first-page":"9729","DOI":"10.1038\/s41598-019-46077-z","volume":"9","author":"NO Pandey","year":"2019","unstructured":"Pandey NO et al (2019) Association of TLR4 and TLR9 polymorphisms and haplotypes with cervical cancer susceptibility. Sci Rep 9(1):9729","journal-title":"Sci Rep"},{"key":"2553_CR27","doi-asserted-by":"publisher","first-page":"106925","DOI":"10.1016\/j.intimp.2020.106925","volume":"88","author":"N Nath","year":"2020","unstructured":"Nath N et al (2020) Polymorphisms and haplotypes of TLR4, TLR9 and CYP1A1 genes possibly interfere with high-risk human papillomavirus infection and cervical cancer susceptibility in Jharkhand, India. International Immunopharmacology 88:106925","journal-title":"International Immunopharmacology"},{"key":"2553_CR28","doi-asserted-by":"crossref","unstructured":"Ramachandran D, D\u00f6rk T (2021) Genomic risk factors for cervical cancer. Cancers 13(20):5137","DOI":"10.3390\/cancers13205137"},{"issue":"4","key":"2553_CR29","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/ijc.25400","volume":"128","author":"II Daud","year":"2011","unstructured":"Daud II et al (2011) Association between toll-like receptor expression and human papillomavirus type 16 persistence. Int J Cancer 128(4):879\u2013886","journal-title":"Int J Cancer"},{"key":"2553_CR30","doi-asserted-by":"crossref","unstructured":"James CD et al (2020) Human papillomavirus 16 E6 and E7 synergistically repress innate immune gene transcription. MSphere 5(1):e00828-19","DOI":"10.1128\/mSphere.00828-19"},{"issue":"5","key":"2553_CR31","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.4049\/jimmunol.178.5.3186","volume":"178","author":"UA Hasan","year":"2007","unstructured":"Hasan UA et al (2007) TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16. Journal of Immunology 178(5):3186\u20133197 ((Baltimore, Md.\u202f: 1950))","journal-title":"Journal of Immunology"},{"issue":"22","key":"2553_CR32","doi-asserted-by":"publisher","first-page":"11396","DOI":"10.1128\/JVI.02151-15","volume":"89","author":"L Pacini","year":"2015","unstructured":"Pacini L et al (2015) Downregulation of Toll-like receptor 9 expression by beta human papillomavirus 38 and implications for cell cycle control. J Virol 89(22):11396\u201311405","journal-title":"J Virol"},{"issue":"3","key":"2553_CR33","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.cell.2009.06.015","volume":"138","author":"Y-H Chiu","year":"2009","unstructured":"Chiu Y-H, Macmillan JB, Chen ZJ (2009) RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138(3):576\u2013591","journal-title":"Cell"},{"key":"2553_CR34","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.3389\/fimmu.2020.02078","volume":"11","author":"AMA Britto","year":"2020","unstructured":"Britto AMA et al (2020) HPV induces changes in innate immune and adhesion molecule markers in cervical mucosa with potential impact on HIV infection. Front Immunol 11:2078","journal-title":"Front Immunol"},{"issue":"2","key":"2553_CR35","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ygyno.2015.05.029","volume":"138","author":"R Aggarwal","year":"2015","unstructured":"Aggarwal R et al (2015) Characterization of Toll-like receptor transcriptome in squamous cell carcinoma of cervix: a case-control study. Gynecol Oncol 138(2):358\u2013362","journal-title":"Gynecol Oncol"},{"key":"2553_CR36","doi-asserted-by":"crossref","unstructured":"Lo Cigno I et al (2020) Human papillomavirus E7 oncoprotein subverts host innate immunity via SUV39H1-mediated epigenetic silencing of immune sensor genes. J Virol  94(4):10-128","DOI":"10.1128\/JVI.01812-19"},{"key":"2553_CR37","doi-asserted-by":"crossref","unstructured":"Chiang C et al (2018) The human papillomavirus E6 oncoprotein targets USP15 and TRIM25 To suppress RIG-I-mediated innate immune signaling. J Virol 92(6):e01737-17","DOI":"10.1128\/JVI.01737-17"},{"issue":"2","key":"2553_CR38","doi-asserted-by":"publisher","first-page":"e29403","DOI":"10.1002\/jmv.29403","volume":"96","author":"Y Hu","year":"2024","unstructured":"Hu Y et al (2024) cGAS-STING-mediated novel nonclassic antiviral activities. J Med Virol 96(2):e29403","journal-title":"J Med Virol"},{"issue":"11","key":"2553_CR39","doi-asserted-by":"publisher","first-page":"e1009028","DOI":"10.1371\/journal.ppat.1009028","volume":"16","author":"BL Uhlorn","year":"2020","unstructured":"Uhlorn BL et al (2020) Vesicular trafficking permits evasion of cGAS\/STING surveillance during initial human papillomavirus infection. PLoS Pathog 16(11):e1009028","journal-title":"PLoS Pathog"},{"issue":"4","key":"2553_CR40","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1172\/JCI129497","volume":"130","author":"X Luo","year":"2020","unstructured":"Luo X et al (2020) HPV16 drives cancer immune escape via NLRX1-mediated degradation of STING. J Clin Investig 130(4):1635\u20131652","journal-title":"J Clin Investig"},{"key":"2553_CR41","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.virusres.2016.11.004","volume":"231","author":"S Hong","year":"2017","unstructured":"Hong S, Laimins LA (2017) Manipulation of the innate immune response by human papillomaviruses. Virus Res 231:34\u201340","journal-title":"Virus Res"},{"key":"2553_CR42","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.critrevonc.2017.11.001","volume":"120","author":"S Tilborghs","year":"2017","unstructured":"Tilborghs S et al (2017) The role of nuclear factor-kappa B signaling in human cervical cancer. Crit Rev Oncol Hematol 120:141\u2013150","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"2553_CR43","doi-asserted-by":"publisher","first-page":"257","DOI":"10.4161\/auto.27162","volume":"10","author":"Z Zhan","year":"2014","unstructured":"Zhan Z et al (2014) Autophagy facilitates TLR4- and TLR3-triggered migration and invasion of lung cancer cells through the promotion of TRAF6 ubiquitination. Autophagy 10(2):257\u2013268","journal-title":"Autophagy"},{"issue":"1","key":"2553_CR44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ygyno.2019.07.023","volume":"155","author":"C Guleria","year":"2019","unstructured":"Guleria C et al (2019) Human papillomavirus 16 infection alters the Toll-like receptors and downstream signaling cascade: a plausible early event in cervical squamous cell carcinoma development. Gynecol Oncol 155(1):151\u2013160","journal-title":"Gynecol Oncol"},{"issue":"5","key":"2553_CR45","doi-asserted-by":"publisher","first-page":"e1003384","DOI":"10.1371\/journal.ppat.1003384","volume":"9","author":"R Karim","year":"2013","unstructured":"Karim R et al (2013) Human papillomavirus (HPV) upregulates the cellular deubiquitinase UCHL1 to suppress the keratinocyte\u2019s innate immune response. PLoS Pathog 9(5):e1003384","journal-title":"PLoS Pathog"},{"issue":"1","key":"2553_CR46","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.virol.2011.12.023","volume":"425","author":"ER Vandermark","year":"2012","unstructured":"Vandermark ER et al (2012) Human papillomavirus type 16 E6 and E 7 proteins alter NF-kB in cultured cervical epithelial cells and inhibition of NF-kB promotes cell growth and immortalization. Virology 425(1):53\u201360","journal-title":"Virology"},{"issue":"1","key":"2553_CR47","doi-asserted-by":"publisher","first-page":"e28310","DOI":"10.1002\/jmv.28310","volume":"95","author":"M Lou","year":"2023","unstructured":"Lou M et al (2023) DNA virus oncoprotein HPV18 E7 selectively antagonizes cGAS-STING-triggered innate immune activation. J Med Virol 95(1):e28310","journal-title":"J Med Virol"},{"issue":"8","key":"2553_CR48","doi-asserted-by":"publisher","first-page":"e1007158","DOI":"10.1371\/journal.ppat.1007158","volume":"14","author":"M Ainouze","year":"2018","unstructured":"Ainouze M et al (2018) Human papillomavirus type 16 antagonizes IRF6 regulation of IL-1\u03b2. PLoS Pathog 14(8):e1007158","journal-title":"PLoS Pathog"},{"key":"2553_CR49","doi-asserted-by":"publisher","first-page":"973875","DOI":"10.3389\/fcimb.2022.973875","volume":"12","author":"C Guo","year":"2022","unstructured":"Guo C et al (2022) Cervicovaginal microbiota significantly changed for HPV-positive women with high-grade squamous intraepithelial lesion. Front Cell Infect Microbiol 12:973875","journal-title":"Front Cell Infect Microbiol"},{"key":"2553_CR50","doi-asserted-by":"crossref","unstructured":"G\u0142owienka-Stodolak M et al (2024) Human papillomavirus infections and the role played by cervical and cervico-vaginal microbiota-evidence from next-generation sequencing studies. Cancers 16(2):399","DOI":"10.3390\/cancers16020399"},{"issue":"2","key":"2553_CR51","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s13167-021-00244-3","volume":"12","author":"E Kudela","year":"2021","unstructured":"Kudela E et al (2021) The interplay between the vaginal microbiome and innate immunity in the focus of predictive, preventive, and personalized medical approach to combat HPV-induced cervical cancer. EPMA J 12(2):199\u2013220","journal-title":"EPMA J"},{"issue":"7610","key":"2553_CR52","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature18847","volume":"535","author":"CA Thaiss","year":"2016","unstructured":"Thaiss CA et al (2016) The microbiome and innate immunity. Nature 535(7610):65\u201374","journal-title":"Nature"},{"key":"2553_CR53","doi-asserted-by":"publisher","first-page":"101714","DOI":"10.1016\/j.tranon.2023.101714","volume":"35","author":"Q Gao","year":"2023","unstructured":"Gao Q et al (2023) Lactobacillus gasseri LGV03 isolated from the cervico-vagina of HPV-cleared women modulates epithelial innate immune responses and suppresses the growth of HPV-positive human cervical cancer cells. Translational Oncology 35:101714","journal-title":"Transl Oncol"},{"issue":"2","key":"2553_CR54","doi-asserted-by":"publisher","first-page":"e29451","DOI":"10.1002\/jmv.29451","volume":"96","author":"N Zhang","year":"2024","unstructured":"Zhang N et al (2024) Cervicovaginal microbiota long-term dynamics and prediction of different outcomes in persistent human papillomavirus infection. J Med Virol 96(2):e29451","journal-title":"J Med Virol"},{"issue":"11","key":"2553_CR55","doi-asserted-by":"publisher","first-page":"5519","DOI":"10.1002\/jmv.28001","volume":"94","author":"B Dong","year":"2022","unstructured":"Dong B et al (2022) Prevotella as the hub of the cervicovaginal microbiota affects the occurrence of persistent human papillomavirus infection and cervical lesions in women of childbearing age via host NF-\u03baB\/C-myc. J Med Virol 94(11):5519\u20135534","journal-title":"J Med Virol"},{"issue":"1","key":"2553_CR56","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/s41467-022-28724-8","volume":"13","author":"A Lebeau","year":"2022","unstructured":"Lebeau A et al (2022) HPV infection alters vaginal microbiome through down-regulating host mucosal innate peptides used by Lactobacilli as amino acid sources. Nat Commun 13(1):1076","journal-title":"Nat Commun"},{"key":"2553_CR57","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.canlet.2020.10.004","volume":"496","author":"S Revathidevi","year":"2021","unstructured":"Revathidevi S et al (2021) APOBEC: a molecular driver in cervical cancer pathogenesis. Cancer Lett 496:104\u2013116","journal-title":"Cancer Lett"},{"issue":"4","key":"2553_CR58","doi-asserted-by":"publisher","first-page":"383","DOI":"10.5582\/bst.2017.01103","volume":"11","author":"L Chen","year":"2017","unstructured":"Chen L et al (2017) APOBEC-mediated genomic alterations link immunity and viral infection during human papillomavirus-driven cervical carcinogenesis. Biosci Trends 11(4):383\u2013388","journal-title":"Biosci Trends"},{"issue":"1","key":"2553_CR59","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1146\/annurev-virology-092920-030354","volume":"9","author":"CJ Warren","year":"2022","unstructured":"Warren CJ, Santiago ML, Pyeon D (2022) APOBEC3: friend or foe in human papillomavirus infection and oncogenesis? Annual Review of Virology 9(1):375\u2013395","journal-title":"Ann Rev Virol"},{"issue":"18","key":"2553_CR60","doi-asserted-by":"publisher","first-page":"6766","DOI":"10.1158\/0008-5472.CAN-04-1091","volume":"64","author":"A Kobayashi","year":"2004","unstructured":"Kobayashi A et al (2004) Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection. Can Res 64(18):6766\u20136774","journal-title":"Can Res"},{"key":"2553_CR61","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13027-020-0272-3","volume":"15","author":"X Liu","year":"2020","unstructured":"Liu X et al (2020) HPV-mediated down-regulation of NOD1 inhibits apoptosis in cervical cancer. Infectious Agents and Cancer 15:6","journal-title":"Infect Agents Cancer"},{"issue":"1","key":"2553_CR62","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12916-022-02248-w","volume":"20","author":"Y Zhang","year":"2022","unstructured":"Zhang Y et al (2022) Upregulation of NOD1 and NOD2 contribute to cancer progression through the positive regulation of tumorigenicity and metastasis in human squamous cervical cancer. BMC Med 20(1):55","journal-title":"BMC Med"},{"issue":"22","key":"2553_CR63","doi-asserted-by":"publisher","first-page":"5295","DOI":"10.1111\/febs.16912","volume":"290","author":"L Hezinger","year":"2023","unstructured":"Hezinger L et al (2023) NOD1 cooperates with HAX-1 to promote cell migration in a RIPK2- and NF-\u0138B-independent manner. FEBS J 290(22):5295\u20135312","journal-title":"FEBS J"},{"issue":"6260","key":"2553_CR64","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1126\/science.aab3291","volume":"350","author":"L Lau","year":"2015","unstructured":"Lau L et al (2015) DNA tumor virus oncogenes antagonize the cGAS-STING DNA-sensing pathway. Science (New York, N.Y.) 350(6260):568\u2013571","journal-title":"Sci (New York, N.Y.)"},{"key":"2553_CR65","doi-asserted-by":"publisher","first-page":"1547466","DOI":"10.3389\/fimmu.2025.1547466","volume":"16","author":"SP Meyer","year":"2025","unstructured":"Meyer SP et al (2025) The role of type I interferon signaling in myeloid anti-tumor immunity. Front Immunol 16:1547466","journal-title":"Front Immunol"},{"issue":"3","key":"2553_CR66","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00430-014-0330-9","volume":"203","author":"F Cannella","year":"2014","unstructured":"Cannella F et al (2014) Interferon lambda 1 expression in cervical cells differs between low-risk and high-risk human papillomavirus-positive women. Med Microbiol Immunol 203(3):177\u2013184","journal-title":"Med Microbiol Immunol"},{"issue":"Pt 11","key":"2553_CR67","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1099\/vir.0.054486-0","volume":"94","author":"F Zhou","year":"2013","unstructured":"Zhou F, Chen J, Zhao K-N (2013) Human papillomavirus 16-encoded E7 protein inhibits IFN-\u03b3-mediated MHC class I antigen presentation and CTL-induced lysis by blocking IRF-1 expression in mouse keratinocytes. J Gen Virol 94(Pt 11):2504\u20132514","journal-title":"J Gen Virol"},{"key":"2553_CR68","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev-immunol-031210-101324","volume":"29","author":"MD Vesely","year":"2011","unstructured":"Vesely MD et al (2011) Natural innate and adaptive immunity to cancer. Annu Rev Immunol 29:235\u2013271","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"2553_CR69","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1172\/JCI31405","volume":"117","author":"JB Swann","year":"2007","unstructured":"Swann JB, Smyth MJ (2007) Immune surveillance of tumors. J Clin Investig 117(5):1137\u20131146","journal-title":"J Clin Investig"},{"issue":"38","key":"2553_CR70","doi-asserted-by":"publisher","first-page":"5191","DOI":"10.1038\/s41388-018-0339-4","volume":"37","author":"D So","year":"2018","unstructured":"So D et al (2018) Cervical cancer is addicted to SIRT1 disarming the AIM2 antiviral defense. Oncogene 37(38):5191\u20135204","journal-title":"Oncogene"},{"issue":"11","key":"2553_CR71","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1038\/s41416-023-02465-x","volume":"129","author":"I Lo Cigno","year":"2023","unstructured":"Lo Cigno I et al (2023) SIRT1 is an actionable target to restore p53 function in HPV-associated cancer therapy. Br J Cancer 129(11):1863\u20131874","journal-title":"Br J Cancer"},{"issue":"1","key":"2553_CR72","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41418-023-01242-w","volume":"31","author":"X Huang","year":"2024","unstructured":"Huang X et al (2024) Activating STING\/TBK1 suppresses tumor growth via degrading HPV16\/18 E7 oncoproteins in cervical cancer. Cell Death Differ 31(1):78\u201389","journal-title":"Cell Death Differ"},{"issue":"1","key":"2553_CR73","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12943-025-02243-8","volume":"24","author":"Y Xie","year":"2025","unstructured":"Xie Y et al (2025) Inflammation in cancer: therapeutic opportunities from new insights. Mol Cancer 24(1):51","journal-title":"Mol Cancer"},{"key":"2553_CR74","doi-asserted-by":"crossref","unstructured":"Fernandez-Avila L et al (2023) The value of CXCL1, CXCL2, CXCL3, and CXCL8 as potential prognosis markers in cervical cancer: evidence of E6\/E7 from HPV16 and 18 in chemokines regulation. Biomedicines 11(10):2655","DOI":"10.3390\/biomedicines11102655"},{"issue":"24","key":"2553_CR75","doi-asserted-by":"publisher","first-page":"5248","DOI":"10.1158\/0008-5472.CAN-15-0732","volume":"75","author":"B Walch-R\u00fcckheim","year":"2015","unstructured":"Walch-R\u00fcckheim B et al (2015) Stromal fibroblasts induce CCL20 through IL6\/C\/EBP\u03b2 to support the recruitment of Th17 cells during cervical cancer progression. Can Res 75(24):5248\u20135259","journal-title":"Can Res"},{"issue":"1","key":"2553_CR76","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1158\/0008-5472.CAN-10-2193","volume":"71","author":"N Schr\u00f6er","year":"2011","unstructured":"Schr\u00f6er N et al (2011) Molecular pathobiology of human cervical high-grade lesions: paracrine STAT3 activation in tumor-instructed myeloid cells drives local MMP-9 expression. Can Res 71(1):87\u201397","journal-title":"Can Res"},{"issue":"8","key":"2553_CR77","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/s41419-024-07030-9","volume":"15","author":"X Gao","year":"2024","unstructured":"Gao X et al (2024) Cervical cancer-produced neuromedin-B reprograms Schwann cells to initiate perineural invasion. Cell Death Dis 15(8):636","journal-title":"Cell Death Dis"},{"key":"2553_CR78","doi-asserted-by":"publisher","first-page":"629350","DOI":"10.3389\/fonc.2021.629350","volume":"11","author":"X Chen","year":"2021","unstructured":"Chen X et al (2021) CXCL10 produced by HPV-positive cervical cancer cells stimulates exosomal PDL1 expression by fibroblasts via CXCR3 and JAK-STAT pathways. Front Oncol 11:629350","journal-title":"Front Oncol"},{"issue":"9","key":"2553_CR79","first-page":"698","volume":"106","author":"Y Jing","year":"1993","unstructured":"Jing Y et al (1993) Distribution and histochemical characteristics of mast cells in stroma of the cervix squamous cell carcinoma. Chin Med J 106(9):698\u2013702","journal-title":"Chin Med J"},{"key":"2553_CR80","doi-asserted-by":"publisher","first-page":"1434450","DOI":"10.3389\/fimmu.2024.1434450","volume":"15","author":"F Zhao","year":"2024","unstructured":"Zhao F et al (2024) Elucidating the role of tumor-associated ALOX5+ mast cells with transformative function in cervical cancer progression via single-cell RNA sequencing. Front Immunol 15:1434450","journal-title":"Front Immunol"},{"key":"2553_CR81","doi-asserted-by":"publisher","first-page":"109790","DOI":"10.1016\/j.biopha.2019.109790","volume":"123","author":"H Cai","year":"2020","unstructured":"Cai H et al (2020) IFI16 promotes cervical cancer progression by upregulating PD-L1 in immunomicroenvironment through STING-TBK1-NF-kB pathway. Biomedicine and Pharmacotherapy = Biomedecine and Pharmacotherapie 123:109790","journal-title":"Biomed Pharmacother = Biomed Pharmacotherapie"},{"issue":"7","key":"2553_CR82","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1158\/0008-5472.CAN-18-1913","volume":"79","author":"B Walch-R\u00fcckheim","year":"2019","unstructured":"Walch-R\u00fcckheim B et al (2019) Cervical cancer-instructed stromal fibroblasts enhance IL23 expression in dendritic cells to support expansion of Th17 cells. Can Res 79(7):1573\u20131586","journal-title":"Can Res"},{"issue":"11","key":"2553_CR83","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1002\/cac2.12486","volume":"43","author":"X Qu","year":"2023","unstructured":"Qu X et al (2023) Interactions of Indoleamine 2,3-dioxygenase-expressing LAMP3+ dendritic cells with CD4+ regulatory T cells and CD8+ exhausted T cells: synergistically remodeling of the immunosuppressive microenvironment in cervical cancer and therapeutic implications. Cancer Communications (London, England) 43(11):1207\u20131228","journal-title":"Cancer Commun (London, England)"},{"issue":"29","key":"2553_CR84","first-page":"e2203040","volume":"9","author":"Z Ou","year":"2022","unstructured":"Ou Z et al (2022) Single-nucleus RNA sequencing and spatial transcriptomics reveal the immunological microenvironment of cervical squamous cell carcinoma. Advanced Science (Weinheim, Baden-Wurttemberg, Germany) 9(29):e2203040","journal-title":"Adv Sci (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"2553_CR85","doi-asserted-by":"crossref","unstructured":"Wang C et al (2024) Identification of Siglec-10 as a new dendritic cell checkpoint for cervical cancer immunotherapy. J Immunother Cancer 12(8):e009404","DOI":"10.1136\/jitc-2024-009404"},{"key":"2553_CR86","doi-asserted-by":"publisher","first-page":"107151","DOI":"10.1016\/j.compbiomed.2023.107151","volume":"163","author":"H Chen","year":"2023","unstructured":"Chen H et al (2023) Integrated immunological analysis of single-cell and bulky tissue transcriptomes reveals the role of interactions between M0 macrophages and na\u00efve CD4+ T cells in the immunosuppressive microenvironment of cervical cancer. Comput Biol Med 163:107151","journal-title":"Comput Biol Med"},{"key":"2553_CR87","doi-asserted-by":"crossref","unstructured":"Lepique AP et al (2009) HPV16 tumor associated macrophages suppress antitumor T cell responses. Clin Cancer Res\u202f: Off J Am Assoc Cancer Res 15(13):4391\u20134400","DOI":"10.1158\/1078-0432.CCR-09-0489"},{"key":"2553_CR88","doi-asserted-by":"crossref","unstructured":"Bonfill-Teixidor E et al (2024) Cervical cancer evades the host immune system through the inhibition of type I interferon and CXCL9 by LIF. Clin Cancer Res : Off J Am Assoc Cancer Res 30(19):4505-16","DOI":"10.1158\/1078-0432.CCR-24-0385"},{"key":"2553_CR89","doi-asserted-by":"crossref","unstructured":"Chen L et al (2023) SCCA1\/SERPINB3 suppresses antitumor immunity and blunts therapy-induced T cell responses via STAT-dependent chemokine production. J Clin Investig 133(15):e163841","DOI":"10.1172\/JCI163841"},{"key":"2553_CR90","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1476-4598-13-60","volume":"13","author":"L-S Chang","year":"2014","unstructured":"Chang L-S et al (2014) Toll-like receptor 9 agonist enhances anti-tumor immunity and inhibits tumor-associated immunosuppressive cells numbers in a mouse cervical cancer model following recombinant lipoprotein therapy. Mol Cancer 13:60","journal-title":"Mol Cancer"},{"issue":"3","key":"2553_CR91","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/2051013617717914","volume":"5","author":"S Smola","year":"2017","unstructured":"Smola S, Trimble C, Stern PL (2017) Human papillomavirus-driven immune deviation: challenge and novel opportunity for immunotherapy. Therapeutic Advances In Vaccines 5(3):69\u201382","journal-title":"Ther Adv Vaccines"},{"issue":"9","key":"2553_CR92","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1007\/s00262-023-03483-7","volume":"72","author":"C Girone","year":"2023","unstructured":"Girone C et al (2023) The RIG-I agonist M8 triggers cell death and natural killer cell activation in human papillomavirus-associated cancer and potentiates cisplatin cytotoxicity. Cancer Immunology, Immunotherapy\u202f: CII 72(9):3097\u20133110","journal-title":"Cancer Immunol Immunother CII"},{"issue":"8","key":"2553_CR93","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1002\/ijc.28416","volume":"134","author":"G Meng","year":"2014","unstructured":"Meng G et al (2014) Multifunctional antitumor molecule 5\u2019-triphosphate siRNA combining glutaminase silencing and RIG-I activation. Int J Cancer 134(8):1958\u20131971","journal-title":"Int J Cancer"},{"key":"2553_CR94","doi-asserted-by":"publisher","first-page":"1342647","DOI":"10.3389\/fimmu.2024.1342647","volume":"15","author":"T Li","year":"2024","unstructured":"Li T et al (2024) STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance. Front Immunol 15:1342647","journal-title":"Front Immunol"},{"issue":"10","key":"2553_CR95","doi-asserted-by":"publisher","first-page":"6437","DOI":"10.1021\/acs.jmedchem.2c01655","volume":"66","author":"J Wang","year":"2023","unstructured":"Wang J et al (2023) Small-molecule modulators targeting Toll-like receptors for potential anticancer therapeutics. J Med Chem 66(10):6437\u20136462","journal-title":"J Med Chem"},{"issue":"11","key":"2553_CR96","doi-asserted-by":"publisher","first-page":"e29238","DOI":"10.1002\/jmv.29238","volume":"95","author":"F Borella","year":"2023","unstructured":"Borella F et al (2023) Recent advances in treating female genital human papillomavirus related neoplasms with topical imiquimod. J Med Virol 95(11):e29238","journal-title":"J Med Virol"},{"key":"2553_CR97","first-page":"136","volume":"136","author":"LA Frank","year":"2019","unstructured":"Frank LA et al (2019) Imiquimod-loaded nanocapsules improve cytotoxicity in cervical cancer cell line. European Journal of Pharmaceutics and Biopharmaceutics\u202f: Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. 136:136","journal-title":"Eur J Pharm Biopharm Off J Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V."},{"issue":"11","key":"2553_CR98","doi-asserted-by":"publisher","first-page":"12671","DOI":"10.1021\/acsnano.9b04207","volume":"13","author":"S-Y Kim","year":"2019","unstructured":"Kim S-Y et al (2019) Lyophilizable and multifaceted Toll-like receptor 7\/8 agonist-loaded nanoemulsion for the reprogramming of tumor microenvironments and enhanced cancer immunotherapy. ACS Nano 13(11):12671\u201312686","journal-title":"ACS Nano"},{"issue":"20","key":"2553_CR99","doi-asserted-by":"publisher","first-page":"12830","DOI":"10.1021\/acsnano.4c00017","volume":"18","author":"L Liu","year":"2024","unstructured":"Liu L et al (2024) Gas-amplified metalloimmunotherapy with dual activation of pyroptosis and the STING pathway for remodeling the immunosuppressive cervical cancer microenvironment. ACS Nano 18(20):12830\u201312844","journal-title":"ACS Nano"},{"issue":"1","key":"2553_CR100","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12943-019-1055-6","volume":"18","author":"M Peng","year":"2019","unstructured":"Peng M et al (2019) Neoantigen vaccine: an emerging tumor immunotherapy. Mol Cancer 18(1):128","journal-title":"Mol Cancer"},{"issue":"3","key":"2553_CR101","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1021\/acsnano.8b08346","volume":"13","author":"W Yang","year":"2019","unstructured":"Yang W et al (2019) In situ dendritic cell vaccine for effective cancer immunotherapy. ACS Nano 13(3):3083\u20133094","journal-title":"ACS Nano"},{"key":"2553_CR102","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.ijbiomac.2022.11.277","volume":"227","author":"P Yuan","year":"2023","unstructured":"Yuan P et al (2023) Evaluation and mechanism of immune enhancement effects of Pleurotus ferulae polysaccharides-gold nanoparticles. Int J Biol Macromol 227:1015\u20131026","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"2553_CR103","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41392-022-01264-9","volume":"8","author":"C Liu","year":"2023","unstructured":"Liu C et al (2023) Single-cell RNA-sequencing reveals radiochemotherapy-induced innate immune activation and MHC-II upregulation in cervical cancer. Signal Transduct Target Ther 8(1):44","journal-title":"Signal Transduct Target Ther"},{"key":"2553_CR104","doi-asserted-by":"crossref","unstructured":"Sato-Kaneko F et al (2017) Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer. JCI Insight 2(18):e93397","DOI":"10.1172\/jci.insight.93397"},{"issue":"1","key":"2553_CR105","first-page":"154","volume":"42","author":"C Cascini","year":"2023","unstructured":"Cascini C et al (2023) Rewiring innate and adaptive immunity with TLR9 agonist to treat osteosarcoma. Journal of Experimental & Clinical Cancer Research\u202f: CR 42(1):154","journal-title":"J Exp Clin Cancer Res CR"},{"issue":"5","key":"2553_CR106","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nrc.2018.6","volume":"18","author":"W Ngwa","year":"2018","unstructured":"Ngwa W et al (2018) Using immunotherapy to boost the abscopal effect. Nat Rev Cancer 18(5):313\u2013322","journal-title":"Nat Rev Cancer"},{"issue":"18","key":"2553_CR107","doi-asserted-by":"publisher","first-page":"8847","DOI":"10.1158\/0008-5472.CAN-07-0321","volume":"67","author":"P Berraondo","year":"2007","unstructured":"Berraondo P et al (2007) Eradication of large tumors in mice by a tritherapy targeting the innate, adaptive, and regulatory components of the immune system. Can Res 67(18):8847\u20138855","journal-title":"Can Res"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-025-02553-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-025-02553-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-025-02553-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T17:18:50Z","timestamp":1757179130000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-025-02553-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,24]]},"references-count":107,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["2553"],"URL":"https:\/\/doi.org\/10.1007\/s00109-025-02553-w","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,24]]},"assertion":[{"value":"23 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}